Aeropharm GmbH Lek Pharmaceuticals d.d. (Lek Pharmaceuticals d.d.) Salutas Pharma GmbH

Poland

All drugs from this manufacturer

  • AIRBUFO FORSPIRO

    The medicine is used for the treatment of asthma in adults and adolescents aged 12 to 17 years, as well as for the treatment of symptoms of chronic obstructive pulmonary disease (COPD) in adults.

    Dosage form: powder for inhalation

    Active substance Dosage
    budesonide 346.3 mcg
    formoterol fumarate dihydrate 10.8 mcg

    ATC: R03AK07